Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR‐ABL1 transcript decline velocity in chronic myeloid leukemia: A 16‐year real‐world study.

Detalles Bibliográficos
Publicado en:Cancer (0008543X) Vol. 132; no. 14; pp. 1 - 15
Autores principales: Mustafa Ali, Moaath K., Zabor, Emily C., Abdurakhmanov, Kamilla, Zureigat, Hadil, Mohamed, Ahmed N., Alchirazi, Muaz Alsabbagh, Dhakal, Aastha, Mushtaq, Ali, Rehman, Naveen, Bawwab, Ameed, Berube, Bryan, Khatib, Lana, Jain, Akriti G., Molina, John C., Balderman, Sophia, Singh, Abhay, Gerds, Aaron T., Sobecks, Ronald, Advani, Anjali S., Carraway, Hetty E.
Formato: Journal Article
Publicado: Wiley-Blackwell Jul2026
Acceso en línea:Ver este registro en EBSCOhost